Insight Molecular Diagnostics Inc Share Price Today: Live Updates & Key Insights
Insight Molecular Diagnostics Inc share price today is $4.255, up 8.67%. The stock opened at $4.13 against the previous close of $3.92, with an intraday high of $4.22 and low of $3.99.
Insight Molecular Diagnostics Inc Share Price Chart
Insight Molecular Diagnostics Inc
Insight Molecular Diagnostics Inc Share Price Performance
Insight Molecular Diagnostics Inc Institutional Holdings
Insight Molecular Diagnostics Inc Market Status
Insight Molecular Diagnostics Inc Fundamentals
Market Cap 122.19 M
PB Ratio 196.272
PE Ratio 0.0
Enterprise Value 96.88 M
Total Assets 35.08 M
Volume 166826
Insight Molecular Diagnostics Inc Company Financials
About Insight Molecular Diagnostics Inc & investment objective
Company Information Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally. The company develops and commercializes laboratory developed tests, kitted research use only tests, and kitted clinical tests. It is developing DetermaCNI, a blood-based monitoring tool that detects progression early after one cycle cancer treatment; and DetermaIO, a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies. The company also offers VitaGraft Kidney, a blood-based transplant monitoring test that quantifies the concentration of donor-derived cell-free DNA for kidney transplantation; VitaGraft Liver, a blood-based transplant monitoring test that quantifies the concentration of donor-derived cell-free DNA for liver transplantation; and GraftAssure, a dd-cfDNA test that uses droplet digital PCR technology to measure the concentration of dd-cfDNA using 48 predefined SNPs. In addition, it provides testing services for biomarker discovery, assay design and development, clinical trial support, and various biomarker tests. The company has a collaboration agreement with Bio-Rad Laboratories, Inc. for the development and commercialization of research use only and in vitro diagnostics kitted transplant products using Bio-Rad's ddPCR instruments and reagents. Insight Molecular Diagnostics Inc. was formerly known as OncoCyte Corporation and changed its name to Insight Molecular Diagnostics Inc. in June 2025. Insight Molecular Diagnostics Inc. was incorporated in 2009 and is based in Nashville, Tennessee.
Organisation Diagnostics & Research
Employees 46
Industry Diagnostics & Research
CEO Mr. Joshua Riggs
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Insight Molecular Diagnostics Inc FAQs
What is the share price of Insight Molecular Diagnostics Inc today?
The current share price of Insight Molecular Diagnostics Inc is $4.255.
Can I buy Insight Molecular Diagnostics Inc shares in India?
Yes, Indian investors can buy Insight Molecular Diagnostics Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Insight Molecular Diagnostics Inc shares in India?
You can easily invest in Insight Molecular Diagnostics Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Insight Molecular Diagnostics Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Insight Molecular Diagnostics Inc.
Can I buy fractional shares of Insight Molecular Diagnostics Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Insight Molecular Diagnostics Inc?
Insight Molecular Diagnostics Inc has a market cap of $122.19 M.
In which sector does Insight Molecular Diagnostics Inc belong?
Insight Molecular Diagnostics Inc operates in the Diagnostics & Research sector.
What documents are required to invest in Insight Molecular Diagnostics Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Insight Molecular Diagnostics Inc?
The PE ratio of Insight Molecular Diagnostics Inc is N/A and the PB ratio is 196.27.